TRDA Entrada Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 10-K/10-Q 八月 5, 2026
$4.41
· % 处于52周区间
· 高于低点
· 至高点
$4.1152周低点
$16.4552周高点
市值 (MRQ)
$172M
P/E (TTM)
-1.1
EPS (TTM)
$-3.97
收入 (TTM)
$5M
TRDA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$4.41
市值 (MRQ)
$172M
P/E (TTM)
-1.1
EPS (TTM)
$-3.97
收入 (TTM)
$5M
ROE (TTM)
-54.1%
52周区间
$4–$16
TRDA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$25M2023-12-31 → 2025-12-31
EPS$-3.472020-12-31 → 2025-12-31
自由现金流$-130M2021-12-31 → 2025-12-31
净利率-3537.7%2023-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | TRDA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.15年均值 ≈-14.9 | ≈-14.9 | · | · | |
| P/S (TTM) | 36.65年均值 ≈7.5 | ≈7.5 | 36.6 | 价格较高 | |
| 市净率 (MRQ) | 0.75年均值 ≈1.7 | ≈1.7 | 3.6 | 低估 | |
| 股价/自由现金流 (TTM) | -1.35年均值 ≈-5.9 | ≈-5.9 | · | · | |
| 市现率 (TTM) | -1.35年均值 ≈-6.4 | ≈-6.4 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 0.65年均值 ≈1.7 | ≈1.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | TRDA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -3767.1%5年均值 ≈-200.4% | ≈-200.4% | -312.3% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -621.1%5年均值 ≈-200.4% | ≈-200.4% | -303.8% | 弱 | |
| 净利润率 (TTM) | -3537.7%5年均值 ≈-179.8% | ≈-179.8% | -391.6% | 弱 | |
| ROA (TTM) | -44.3%5年均值 ≈-12.4% | ≈-12.4% | -30.6% | 持平 | |
| ROE (TTM) | -54.1%5年均值 ≈-18.6% | ≈-18.6% | -30.2% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | TRDA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 10.95年均值 ≈17.6 | ≈17.6 | 8.6 | 流动性强 | |
| Quick Ratio (速动比率) | 3.75年均值 ≈12.5 | ≈12.5 | 5.1 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | TRDA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -87.9% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | TRDA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.15年均值 ≈0.3 | ≈0.3 | 0.1 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$167.2K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
8.8%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $-1.01 | $-1.07 | 5.7% |
| 2026年3月31日 | $-0.95 | $-1.06 | 10.2% | |
| 2025年12月31日 | $-0.94 | $-1.17 | 19.9% | |
| 2025年9月30日 | $-1.06 | $-0.96 | -10.6% | |
| 2025年6月30日 | $-1.04 | $-0.86 | -20.3% | |
| 2025年3月31日 | $-0.42 | $-0.80 | 47.8% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $25M | $211M | $129M | |
| R&D Expense | $142M | $125M | $100M | |
| SG&A Expense | $41M | $38M | $32M | |
| Operating Expenses | $183M | $164M | $132M | |
| Operating Income | $-158M | $47M | $-3M | |
| Other Non-op | $15M | $19M | $15M | |
| Income Tax | $924.0K | $859.0K | $19M | |
| Net Income | $-144M | $66M | $-7M | |
| EPS (Basic) | $-3.47 | $1.76 | $-0.20 | |
| EPS (Diluted) | $-3.47 | $1.68 | $-0.20 | |
| Shares (Basic) | 41,371,486 | 37,306,363 | 33,050,319 | |
| Shares (Diluted) | 41,371,486 | 39,003,169 | 33,050,319 | |
| EBITDA | $-158M | $47M | $-3M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $90M | $101M | $68M | |
| Prepaid Expense | $9M | $16M | $12M | |
| Current Assets | $306M | $440M | $370M | |
| PP&E (Net) | $7M | $11M | $11M | |
| PP&E (Gross) | $17M | $20M | $17M | |
| Accum. Depreciation | $10M | $9M | $6M | |
| Other Non-current Assets | $70.0K | $284.0K | $3M | |
| Total Assets | $377M | $526M | $469M | |
| Accounts Payable | $2M | $4M | $3M | |
| Accrued Liabilities | $18M | $13M | $11M | |
| Current Liabilities | $24M | $39M | $159M | |
| Capital Leases | $47M | $52M | $60M | |
| Total Liabilities | $71M | $98M | $227M | |
| Common Stock | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | $579M | $558M | $437M | |
| Retained Earnings | $-273M | $-129M | $-195M | |
| AOCI | $652.0K | $-43.0K | $195.0K | |
| Stockholders' Equity | $306M | $429M | $242M | |
| Liabilities + Equity | $377M | $526M | $469M | |
| Shares Outstanding | 38,284,221 | 37,574,538 | 33,437,296 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $20M | $18M | $13M | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-129M | $-42M | $140M | |
| CapEx | $1M | $3M | $6M | |
| Investing Cash Flow | $117M | $-28M | $-138M | |
| Financing Cash Flow | $887.0K | $103M | $21M | |
| Net Change in Cash | $-11M | $34M | $22M | |
| Taxes Paid | $2M | $5M | $15M | |
| Free Cash Flow | $-130M | $-45M | $134M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -621.1% | 22.3% | -2.5% | |
| Net Margin | -565.5% | 31.1% | -5.2% | |
| EBITDA Margin | -621.1% | 22.3% | -2.5% | |
| ROA | -31.8% | 13.2% | -1.8% | |
| ROE | -41.9% | 15.4% | -2.7% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.5 | 11.1 | 2.3 | |
| Quick Ratio | 3.7 | 2.6 | 0.4 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.4 | 0.4 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $8.00 | $11.41 | $7.25 | |
| Revenue / Share | $0.61 | $5.40 | $3.90 | |
| Cash Flow / Share | $-3.11 | $-1.07 | $4.23 | |
| Cash / Share | $2.36 | $2.69 | $2.02 | |
| EPS (TTM) | $-3.47 | $1.68 | $-0.20 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -87.9% | 63.4% | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $25M | $211M | $129M | |
| Net Income TTM | $-144M | $66M | $-7M | |
| Market Cap | $394M | $650M | $505M | |
| P/E | -3.0 | 10.3 | -75.5 | |
| P/S | 15.5 | 3.1 | 3.9 | |
| P/B | 1.3 | 1.5 | 2.1 | |
| P / Tangible Book | 1.3 | 1.5 | 2.1 | |
| P / Cash Flow | -3.1 | -15.6 | 3.6 | |
| P / FCF | -3.0 | -14.5 | 3.8 | |
| Earnings Yield | -33.8% | 9.7% | -1.3% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $898.0K | $875.0K | $1M | $2M | $2M | $21M | $37M | $20M | $95M | $59M | $42M | $44M | $18M | $25M | · | $0 | |
| R&D Expense | $35M | $33M | $34M | $38M | $38M | $32M | $33M | $31M | $32M | $29M | $28M | $22M | $26M | $23M | $16M | $19M | |
| SG&A Expense | $10M | $10M | $10M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $8M | $8M | $10M | $7M | |
| Operating Expenses | $46M | $43M | $44M | $49M | $49M | $42M | $43M | $41M | $41M | $38M | $37M | $30M | $34M | $31M | $26M | $26M | |
| Operating Income | $-45M | $-42M | $-42M | $-47M | $-47M | $-22M | $-6M | $-22M | $53M | $21M | $5M | $14M | $-16M | $-6M | $-26M | $-26M | |
| Other Non-op | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $3M | $950.0K | $799.0K | |
| Income Tax | $35.0K | $38.0K | $92.0K | $654.0K | $178.0K | $0 | $-2M | $-2M | $3M | $2M | $19M | $-17M | $14M | $4M | $0 | $0 | |
| Net Income | $-43M | $-40M | $-39M | $-44M | $-43M | $-17M | $1M | $-14M | $55M | $23M | $-10M | $35M | $-26M | $-7M | $-25M | $-25M | |
| EPS (Basic) | $-1.01 | $-0.95 | $-0.95 | $-1.06 | $-1.04 | $-0.42 | $-0.20 | $-0.35 | $1.61 | $0.70 | $-0.28 | $1.07 | $-0.78 | $-0.21 | $-0.79 | $-0.80 | |
| EPS (Diluted) | $-1.01 | $-0.95 | $-0.95 | $-1.06 | $-1.04 | $-0.42 | $-0.20 | $-0.35 | $1.55 | $0.68 | $-0.23 | $1.02 | $-0.78 | $-0.21 | $-0.79 | $-0.80 | |
| Shares (Basic) | 42,221,665 | 41,836,275 | · | 41,462,567 | 41,338,752 | 41,073,732 | · | 40,629,602 | 34,180,549 | 33,497,072 | · | 33,281,287 | 33,163,320 | 32,374,299 | · | 31,298,052 | |
| Shares (Diluted) | 42,221,665 | 41,836,275 | · | 41,462,567 | 41,338,752 | 41,073,732 | · | 40,629,602 | 35,507,029 | 34,790,925 | · | 34,775,451 | 33,163,320 | 32,374,299 | · | 31,298,052 | |
| EBITDA | $-45M | $-42M | · | $-47M | $-47M | $-22M | · | $-22M | $53M | $21M | · | $14M | $-16M | · | · | $-26M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $76M | $90M | $93M | $72M | $68M | $101M | $78M | $185M | $68M | $68M | $52M | $80M | $228M | $45M | $53M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $162M | |
| Prepaid Expense | $9M | $11M | $9M | $10M | $14M | $19M | $16M | $13M | $12M | $9M | $12M | $24M | $10M | $16M | $21M | $19M | |
| Current Assets | $233M | $267M | $306M | $338M | $369M | $403M | $440M | $465M | $490M | $414M | $370M | $383M | $390M | $434M | $210M | $235M | |
| PP&E (Net) | $6M | $7M | $7M | $8M | $10M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $9M | $8M | $7M | |
| PP&E (Gross) | $16M | $17M | $17M | $19M | $21M | $21M | $20M | $19M | $19M | $18M | $17M | $16M | $15M | $13M | $11M | $10M | |
| Accum. Depreciation | $11M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | $3M | |
| Other Non-current Assets | $118.0K | $90.0K | $70.0K | $163.0K | $199.0K | $239.0K | $284.0K | $746.0K | $747.0K | $3M | $3M | $3M | $538.0K | $14M | $5M | $954.0K | |
| Total Assets | $299M | $336M | $377M | $413M | $449M | $486M | $526M | $555M | $582M | $511M | $469M | $485M | $494M | $476M | $252M | $274M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $2M | $2M | $4M | $1M | $2M | $3M | $3M | $752.0K | $2M | $6M | $6M | $1M | |
| Accrued Liabilities | $13M | $12M | $18M | $16M | $12M | $8M | $13M | $13M | $11M | $9M | $11M | $10M | $7M | $12M | $8M | $12M | |
| Current Liabilities | $21M | $19M | $24M | $24M | $20M | $18M | $39M | $71M | $86M | $174M | $159M | $165M | $126M | $148M | $22M | $22M | |
| Capital Leases | $44M | $45M | $47M | $48M | $49M | $50M | $52M | $54M | $56M | $58M | $60M | $62M | $66M | $9M | $18M | $20M | |
| Total Liabilities | $65M | $65M | $71M | $72M | $69M | $69M | $98M | $132M | $152M | $241M | $227M | $238M | $287M | $246M | $40M | $41M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $589M | $583M | $579M | $574M | $569M | $564M | $558M | $552M | $547M | $441M | $437M | $433M | $429M | $425M | $403M | $400M | |
| Retained Earnings | $-356M | $-313M | $-273M | $-234M | $-190M | $-147M | $-129M | $-130M | $-116M | $-171M | $-195M | $-185M | $-221M | $-195M | $-188M | $-164M | |
| AOCI | $66.0K | $246.0K | $652.0K | $621.0K | $400.0K | $437.0K | $-43.0K | $972.0K | $-329.0K | $-246.0K | $195.0K | $-496.0K | $-1M | $-642.0K | $-2M | $-3M | |
| Stockholders' Equity | $233M | $271M | $306M | $341M | $380M | $417M | $429M | $422M | $430M | $269M | $242M | $247M | $207M | $230M | $213M | $233M | |
| Liabilities + Equity | $299M | $336M | $377M | $413M | $449M | $486M | $526M | $555M | $582M | $511M | $469M | $485M | $494M | $476M | $252M | $274M | |
| Shares Outstanding | 38,936,669 | 38,820,616 | 38,284,221 | 38,219,232 | 38,033,970 | 37,942,283 | 37,574,538 | 37,400,499 | 37,172,496 | 33,604,053 | 33,437,296 | 33,340,216 | 33,205,693 | 33,133,736 | 31,394,767 | 31,325,373 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-32M | $-42M | $-32M | $-28M | $-29M | $-39M | $-32M | $-24M | $40M | $-26M | $-4M | $-24M | $-35M | $203M | $-27M | $-27M | |
| CapEx | $11.0K | $44.0K | $-207.0K | $-171.0K | $275.0K | $1M | $635.0K | $639.0K | $1M | $838.0K | $976.0K | $1M | $2M | $2M | $708.0K | $810.0K | |
| Investing Cash Flow | $55M | $27M | $29M | $49M | $34M | $5M | $53M | $-83M | $-24M | $26M | $19M | $-4M | $-113M | $-40M | $19M | $-10M | |
| Stock Issued | · | · | · | $0 | · | · | · | $-392.0K | $100M | $0 | · | $0 | $0 | $19M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $350.0K | $100.0K | $192.0K | $8.0K | $337.0K | $350.0K | $1M | $-11.0K | $101M | $206.0K | $690.0K | $368.0K | $443.0K | $20M | $358.0K | $60.0K | |
| Net Change in Cash | $23M | $-15M | $-3M | $21M | $5M | $-33M | $23M | $-107M | $117M | $834.0K | $16M | $-28M | $-148M | $182M | $-8M | $-38M | |
| Free Cash Flow | · | $-42M | · | · | · | $-40M | · | · | · | $-26M | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5007.0% | -4834.6% | · | -2915.2% | -2402.5% | -106.0% | · | -110.7% | 56.4% | 35.7% | · | 32.0% | -89.7% | · | · | · | |
| Net Margin | -4762.0% | -4539.1% | · | -2734.4% | -2210.4% | -84.4% | · | -71.7% | 58.1% | 39.7% | · | 81.1% | -142.7% | · | · | · | |
| EBITDA Margin | -5007.0% | -4834.6% | · | -2915.2% | -2402.5% | -106.0% | · | -110.7% | 56.4% | 35.7% | · | 32.0% | -89.7% | · | · | · | |
| ROA | -11.4% | -9.7% | · | -9.1% | -8.4% | -3.5% | · | -2.7% | 10.2% | 4.8% | · | 9.3% | -6.6% | · | · | -12.4% | |
| ROE | -14.0% | -11.5% | · | -11.6% | -10.7% | -5.1% | · | -4.2% | 17.3% | 9.4% | · | 14.8% | -11.2% | · | · | -31.3% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 13.9 | · | 14.1 | 18.6 | 21.9 | · | 6.6 | 5.7 | 2.4 | · | 2.3 | 3.1 | · | · | 10.9 | |
| Quick Ratio | 4.6 | 4.0 | · | 3.9 | 3.7 | 3.7 | · | 1.1 | 2.2 | 0.4 | · | 0.3 | 0.6 | · | · | 10.0 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.2 | 0.1 | · | 0.1 | 0.0 | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.99 | $6.98 | · | $8.91 | $9.98 | $11.00 | · | $11.30 | $11.57 | $8.02 | · | $7.40 | $6.23 | · | · | $7.45 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.04 | $0.05 | $0.50 | · | $0.48 | $2.67 | $1.70 | · | $1.26 | $0.55 | · | · | · | |
| Cash Flow / Share | · | $-1.00 | · | · | · | $-0.94 | · | · | · | $-0.73 | · | · | · | · | · | · | |
| Cash / Share | $2.55 | $1.97 | · | $2.44 | $1.91 | $1.79 | · | $2.09 | $4.98 | $2.04 | · | $1.56 | $2.40 | · | · | $1.70 | |
| EPS (TTM) | $-3.97 | $-4.00 | · | $-2.72 | $-2.01 | $0.58 | · | $1.65 | $3.02 | $0.69 | · | $-0.76 | $-2.58 | $-2.44 | · | $13.62 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $6M | · | $62M | $79M | $172M | · | $215M | $239M | $163M | · | · | · | $25M | · | · | |
| Net Income TTM | $-166M | $-166M | · | $-103M | $-73M | $25M | · | $55M | $104M | $23M | · | $-22M | $-82M | $-77M | · | $-88M | |
| Market Cap | $287M | $490M | · | $222M | $256M | $343M | · | $598M | $530M | $476M | · | $527M | $503M | · | · | $494M | |
| P/E | -1.9 | -3.2 | · | -2.1 | -3.3 | 15.6 | · | 9.7 | 4.7 | 20.5 | · | -20.8 | -5.9 | -5.9 | · | 1.2 | |
| P/S | 61.2 | 85.4 | · | 3.6 | 3.2 | 2.0 | · | 2.8 | 2.2 | 2.9 | · | · | · | · | · | · | |
| P/B | 1.2 | 1.8 | · | 0.7 | 0.7 | 0.8 | · | 1.4 | 1.2 | 1.8 | · | 2.1 | 2.4 | · | · | 2.1 | |
| P / Tangible Book | 1.2 | 1.8 | · | 0.7 | 0.7 | 0.8 | · | 1.4 | 1.2 | 1.8 | · | 2.1 | 2.4 | 2.1 | · | 2.1 | |
| P / Cash Flow | · | -11.8 | · | · | · | -8.9 | · | · | · | -18.7 | · | · | · | · | · | · | |
| Earnings Yield | -53.9% | -31.7% | · | -46.9% | -29.9% | 6.4% | · | 10.3% | 21.2% | 4.9% | · | -4.8% | -17.0% | -16.8% | · | 86.4% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $25M | $211M | $129M | · | · |
| 营业利润率 % | -621.1% | 22.3% | -2.5% | · | · |
| 净收入 | $-144M | $66M | $-7M | $-95M | $-51M |
| 稀释后每股收益 (EPS) | $-3.47 | $1.68 | $-0.20 | $-3.02 | $-8.16 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 12.5 | 11.1 | 2.3 | · | 44.5 |
| 速动比率 | 3.7 | 2.6 | 0.4 | · | 43.3 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-130M | $-45M | $134M | · | $-55M |
机构持有人 (13F) 135 家申报者 · $253.8M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
135
持有价值
$253.8M
新仓位
28
已退出持仓
16
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 28 (+6 与上一季度对比) | 16 (+4 与上一季度对比) | 53 (+6 与上一季度对比) | 31 (+1 与上一季度对比) | +2.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $37335293 | 5072730 | 14.71% | 股份 |
| 5AM Venture Management, LLC | $29854949 | 4056379 | 11.76% | 股份 |
| MPM ASSET MANAGEMENT LLC | $25410160 | 4381062 | 10.01% | 股份 |
| BlackRock, Inc. | $19013332 | 2583333 | 7.49% | 股份 |
| VANGUARD GROUP INC | $16781689 | 1632460 | 6.61% | 股份 |
| Merck & Co., Inc. | $12804692 | 1739768 | 5.05% | 股份 |
| StepStone Group LP | $9607316 | 761277 | 3.79% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $9344506 | 1269634 | 3.68% | 股份 |
| MPM BIOIMPACT LLC | $9222470 | 1253053 | 3.63% | 股份 |
| TCG Crossover Management, LLC | $7803293 | 1060230 | 3.07% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $7024524 | 954419 | 2.77% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $5622738 | 763959 | 2.22% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $5281368 | 717430 | 2.08% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $5148591 | 699537 | 2.03% | 股份 |
| STATE STREET CORP | $4391543 | 596677 | 1.73% | 股份 |
| JPMORGAN CHASE & CO | $3827683 | 496457 | 1.51% | 股份 |
| CITADEL ADVISORS LLC | $2902217 | 394323 | 1.14% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $2769577 | 376136 | 1.09% | 股份 |
| NORTHERN TRUST CORP | $2281173 | 309942 | 0.90% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2233458 | 303459 | 0.88% | 股份 |
| Nantahala Capital Management, LLC | $2212232 | 300575 | 0.87% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1870397 | 254130 | 0.74% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1450921 | 197136 | 0.57% | 股份 |
| Longaeva Partners L.P. | $1436944 | 195237 | 0.57% | 股份 |
| MORGAN STANLEY | $1410544 | 191650 | 0.56% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1405760 | 191000 | 0.55% | 股份 |
| Quantinno Capital Management LP | $1389855 | 188839 | 0.55% | 股份 |
| Lynx1 Capital Management LP | $1314540 | 178606 | 0.52% | 股份 |
| GOLDMAN SACHS GROUP INC | $1305247 | 177343 | 0.51% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1233875 | 167646 | 0.49% | 股份 |
| Woodline Partners LP | $1071616 | 145600 | 0.42% | 股份 |
| Trexquant Investment LP | $1031452 | 140143 | 0.41% | 股份 |
| MOORE CAPITAL MANAGEMENT, LP | $772800 | 105000 | 0.30% | 股份 |
| Cubist Systematic Strategies, LLC | $711521 | 122676 | 0.28% | 股份 |
| XTX Topco Ltd | $701680 | 95337 | 0.28% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $699524 | 95044 | 0.28% | 股份 |
| Allspring Global Investments Holdings, LLC | $688440 | 93538 | 0.27% | 股份 |
| ROYCE & ASSOCIATES LP | $610159 | 82902 | 0.24% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $586599 | 79701 | 0.23% | 股份 |
| Bank of New York Mellon Corp | $581955 | 79070 | 0.23% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $533747 | 72520 | 0.21% | 股份 |
| AMERIPRISE FINANCIAL INC | $518107 | 70395 | 0.20% | 股份 |
| Qube Research & Technologies Ltd | $448018 | 60872 | 0.18% | 股份 |
| CANTOR FITZGERALD, L. P. | $441600 | 60000 | 0.17% | 股份 |
| BANK OF AMERICA CORP /DE/ | $426343 | 57927 | 0.17% | 股份 |
| Nuveen, LLC | $417879 | 56777 | 0.16% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $399297 | 31640 | 0.16% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $398272 | 54113 | 0.16% | 股份 |
| TD Asset Management Inc | $394408 | 53588 | 0.16% | 股份 |
| ExodusPoint Capital Management, LP | $388365 | 52767 | 0.15% | 股份 |
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| ANSBERT GADICKE, LUKE EVNIN, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM Asset Management Investors BV2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM BIOVENTURES 2018, L.P., MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014, L.P., MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, Todd Foley | 2026年9月10日 | 9.90% | 修订 | · | SEC |
| 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar, Scott M. Rocklage | 2025年11月18日 | 10.80% | 修订 | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker, Julian C. Baker ×2 申报 | 2024年6月26日 | · | 初始申报 | 被动投资 | SEC |
| MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2018, L.P., MPM BioVentures 2018 (B), L.P., MPM Asset Management Investors BV2018 LLC, MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, Ansbert Gadicke, Luke Evnin, Todd Foley, Edward Hurwitz | 2021年11月12日 | · | 初始申报 | 被动投资 | SEC |
| 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Dr. Kush Parmar, Dr. Scott M. Rocklage | 2021年11月12日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 14 位内幕人士 · 5 位高管 · 10 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Dipal Doshi | CEO | 2026年9月2日 F | 517290 | 0 | 0 | $0 |
| Kory James Wentworth | Chief Financial Officer | 2026年9月2日 F | 117277 | 0 | 5 | $-433579 |
| Natarajan Sethuraman | President, Research & Develop. | 2026年9月2日 F | 214238 | 0 | 1 | $-398709 |
| Nathan J Dowden | President & COO | 2026年9月2日 F | 196060 | 0 | 3 | $-425737 |
| Nerissa Kreher | Chief Medical Officer | 2023年9月1日 A | 40037 | 0 | 0 | $0 |
| Kush Parmar | 董事 | 2026年8月10日 S | 2691337 | 0 | 6 | $-3645964 |
| Maha Radhakrishnan | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Gina Chapman | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Bernhardt G Zeiher | 董事 | 2026年6月10日 A | 5000 | 1 | 0 | $29300 |
| Mary Thistle | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Peter S Kim | 董事 | 2026年6月10日 A | 117412 | 0 | 0 | $0 |
| John F Crowley | 董事 | 2023年6月8日 A | 5000 | 0 | 0 | $0 |
| Carole Nuechterlein | 董事 | 2022年6月2日 A | · | 0 | 0 | $0 |
| Todd Foley | 董事 | 2022年6月2日 A | 4425784 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 23 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBRN · iShares Trust | 0.15% | 1770 SH | 2026年9月11日 | 每日 |
| HAPS · Harbor ETF Trust | 0.13% | 33369 NS | 2026年7月31日 | N-PORT |
| IWC · iShares Trust | 0.04% | 100286 SH | 2026年9月11日 | 每日 |
| IBB · iShares Trust | 0.01% | 203253 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.01% | 2925 SH | 2026年10月23日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 169170 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 25636 SH | 2026年8月19日 | 每日 |
| RSSL · Global X Funds | 0.01% | 14068 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.01% | 753989 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 34287 SH | 2026年10月23日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.00% | 108498 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 2856 NS | 2026年7月31日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.00% | 12272 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 3020 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4231 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 4896 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 7674 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 283038 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 953727 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1999 SH | 2026年8月19日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 2069 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.00% | 57325 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 269374 SH | 2026年9月11日 | 每日 |
TRDA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$20.00
+353.5%
5 35.7%
强烈买入
7 50.0%
买入
2 14.3%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
4 位分析师 · 2026-10-24平均目标 $19.00 +330.8%
← 低于所有目标
当前价格 $4.41
最低$11.00
平均值$19.00
最高$25.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 5, 2026 申报